ATE8966T1 - Analgetische potenzierung. - Google Patents

Analgetische potenzierung.

Info

Publication number
ATE8966T1
ATE8966T1 AT82301337T AT82301337T ATE8966T1 AT E8966 T1 ATE8966 T1 AT E8966T1 AT 82301337 T AT82301337 T AT 82301337T AT 82301337 T AT82301337 T AT 82301337T AT E8966 T1 ATE8966 T1 AT E8966T1
Authority
AT
Austria
Prior art keywords
analgesic potentiation
zomepirac
analgesic
potentiation
nonanalgesic
Prior art date
Application number
AT82301337T
Other languages
English (en)
Inventor
Joseph Francis Gardocki
Original Assignee
Mcneilab, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneilab, Inc. filed Critical Mcneilab, Inc.
Application granted granted Critical
Publication of ATE8966T1 publication Critical patent/ATE8966T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT82301337T 1981-03-17 1982-03-16 Analgetische potenzierung. ATE8966T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/244,562 US4338324A (en) 1981-03-17 1981-03-17 Analgesic potentiation
EP82301337A EP0061287B1 (de) 1981-03-17 1982-03-16 Analgetische Potenzierung

Publications (1)

Publication Number Publication Date
ATE8966T1 true ATE8966T1 (de) 1984-09-15

Family

ID=22923263

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82301337T ATE8966T1 (de) 1981-03-17 1982-03-16 Analgetische potenzierung.

Country Status (9)

Country Link
US (1) US4338324A (de)
EP (1) EP0061287B1 (de)
JP (1) JPS57159715A (de)
KR (1) KR830008678A (de)
AT (1) ATE8966T1 (de)
AU (1) AU551108B2 (de)
CA (1) CA1178888A (de)
DE (1) DE3260567D1 (de)
PH (1) PH16941A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
EP1056443B1 (de) 1998-02-25 2004-05-06 Abbott Laboratories Butorphanol enthaltende formulierungen mit verzögerter freisetzung
US20040198723A1 (en) * 2002-01-22 2004-10-07 Karen Gibson Method of treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2861595D1 (en) * 1978-07-10 1982-03-11 Mcneilab Inc Pharmaceutical composition comprising a 5-aroyl-1-c1-5 alkyl-pyrrole-2-acetic acid compound and acetaminophen or acetylsalicylic acid
US4233313A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4233317A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation

Also Published As

Publication number Publication date
CA1178888A (en) 1984-12-04
US4338324A (en) 1982-07-06
AU8159882A (en) 1982-09-23
PH16941A (en) 1984-04-24
AU551108B2 (en) 1986-04-17
JPS57159715A (en) 1982-10-01
EP0061287A1 (de) 1982-09-29
KR830008678A (ko) 1983-12-14
DE3260567D1 (en) 1984-09-20
EP0061287B1 (de) 1984-08-15

Similar Documents

Publication Publication Date Title
NL7903824A (nl) Samenstelling voor de therapeutische behandeling van chronische uremiepatienten, die periodiek een hemodialyse ondergaan.
EA200300628A1 (ru) Соединения, специфические к аденозиновому a, aи aрецептору, и их применение
YU75093A (sh) Transdermalni sistem za davanje koji sadrži acetilsalicilnu kiselinu za antitromboznu terapiju i profilaksu raka
FI863703L (fi) Glykocidderivat.
DK200184D0 (da) Baeger til medicin
PT90049A (pt) Forma de dosagem para administrar um medicamento para terapia humana
DK165233C (da) Doseringsventil
DK0785769T3 (da) Terapeutisk vitamin-calcium-kombination i form af en galenisk enhedsdosistablet, fremgangsmåde til fremstilling af denne sa
DE68909409D1 (de) Heilmitteldosierung zur verabreichung an fische.
ATE8966T1 (de) Analgetische potenzierung.
HU9203022D0 (en) Pharmaceutical preparatives with upriflavone content methods for production and medical utilization of said compounds
DK0398217T3 (da) Dehydrocholecalciferolderivater
ES2019634B3 (es) Terapia con clorfeniramina.
FI834362A7 (fi) Korkean verenpaineen hoitoon käytettäviä yhdisteitä.
IT1224250B (it) Associzione del depiprazolo con la morfina
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
TR199701604T2 (xx) Pirol t�revleri i�in yeni ba�vuru
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
FI930097A7 (fi) Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten
AR002946A1 (es) Un conjunto para uso en el tratamiento o la prevencion de la osteoporosis en los mamiferos de acuerdo con una dieta ciclica.
IT1145989B (it) Composto farmaceutico contenente 1.2.3.carbossipropionil ossietile 2 metile 5 nitroimidazolo quale a gente terapeutico attivo contro le malattie causate da germi anaerobi
IT8222262V0 (it) Apparecchio per effettuare massaggi ai piedi a scopo terapeutico.
IT8223013V0 (it) Dispositivo per determinare l'intervallo di tempo per la somministrazione di dibecacina solfato in funzione della alterata funzionalita' renale di un paziente.
BE888324A (fr) Medicament pour favoriser la guerison du diabete.
RO81783A3 (ro) Medicament pentru tratamentul maladiei neoplazice

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee